Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer

NCT01417000 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Pancreatic Cancer

Interventions

BIOLOGICAL: GVAX Pancreas
BIOLOGICAL: CRS-207
DRUG: Cyclophosphamide

Sponsor

Aduro Biotech, Inc.

Collaborators

[object Object]